Literature DB >> 21035227

Risk factor associations with clinical distal symmetrical polyneuropathy and various neuropathy screening instruments and protocols in type 1 diabetes.

G Pambianco1, T Costacou, Elsa Strotmeyer, T J Orchard.   

Abstract

OBJECTIVE: To determine whether DSP and neuropathy-assessment instruments used by non-physicians have similar risk factors. RESEARCH DESIGN AND METHODS: analyses were cross-sectional (n=176).
RESULTS: risk factors were similar for DSP and screening devices.
CONCLUSIONS: these data support the clinical utility of neuropathy screening devices used by non-physician personnel. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21035227      PMCID: PMC3093294          DOI: 10.1016/j.diabres.2010.09.031

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  14 in total

1.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  The hypertension detection and follow-up program: Hypertension detection and follow-up program cooperative group.

Authors: 
Journal:  Prev Med       Date:  1976-06       Impact factor: 4.018

3.  Can clinical factors estimate insulin resistance in type 1 diabetes?

Authors:  K V Williams; J R Erbey; D Becker; S Arslanian; T J Orchard
Journal:  Diabetes       Date:  2000-04       Impact factor: 9.461

4.  Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.

Authors:  Bruce A Perkins; Jaspreet Grewal; Eduardo Ng; Mylan Ngo; Vera Bril
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

5.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

6.  Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol.

Authors:  G R Warnick; J Benderson; J J Albers
Journal:  Clin Chem       Date:  1982-06       Impact factor: 8.327

7.  Vascular risk factors and diabetic neuropathy.

Authors:  Solomon Tesfaye; Nish Chaturvedi; Simon E M Eaton; John D Ward; Christos Manes; Constantin Ionescu-Tirgoviste; Daniel R Witte; John H Fuller
Journal:  N Engl J Med       Date:  2005-01-27       Impact factor: 91.245

8.  Diabetic nerve conduction abnormalities in the primary care setting.

Authors:  Aaron I Vinik; Xuan Kong; J Thomas Megerian; Shai N Gozani
Journal:  Diabetes Technol Ther       Date:  2006-12       Impact factor: 6.118

9.  Cardiovascular risk factors predicting the development of distal symmetrical polyneuropathy in people with type 1 diabetes: A 9-year follow-up study.

Authors:  Latika Sibal; Huong Nai Law; Janice Gebbie; Philip Home
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

10.  Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide.

Authors:  P Fossati; L Prencipe
Journal:  Clin Chem       Date:  1982-10       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.